All News

July 8, 2024

GeneMAP discovery platform will help define functions for ‘orphan’ metabolic proteins 

The combination of genomics and metabolism identified a long-sought mitochondrial choline transporter.

By Leigh MacMillan
Cover of the VI4 AiR (Artist-in-Residence) 2022 annual report: B cells, antibodies and strands of free-flowing DNA represent B cell genome modification and the formation of unique antibodies. Illustration by Nadia Kafil, a UT-Austin biochemistry major who participated in the nationwide AiR program in the lab of Columbia University professor Uttiya Basu, PhD.
July 5, 2024

Vanderbilt Vaccine Center to begin artist-in-residence program this fall

The six-month-long “Visualizing Virology” residency is an extension of the VI4 Artist-in-Residence Program established in 2019 by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), and supported by the Burroughs Wellcome Fund.

By Bill Snyder
Marilyn Dubree, MSN, RN, NE-BC, spent more than 45 years promoting excellence in nursing practice at Vanderbilt. (photo by Erin O. Smith)
July 3, 2024

Event celebrates Marilyn Dubree’s history of service at VUMC

In recognition of Marilyn Dubree’s generosity and legacy of service, VUMC will immediately activate the Marilyn Dubree Chief Nursing Officer Directorship.

By Matt Batcheldor
July 3, 2024

Couple’s legacy of giving results in transformative change in endocrinology at Vanderbilt

“As I worked at Vanderbilt, I became so attached to the division, and when I had the ability to do it, I wanted to give back.”

By Jill Clendening
July 3, 2024

Her positive mindset makes Jessie Rand an invaluable team member

“There isn’t just one story of how Jessie makes those she serves her highest priority, there are thousands,” wrote one clinic co-worker. “Her big laugh and can-do attitude are contagious.”

By Jill Clendening
Sarah Tishkoff, PhD
July 2, 2024

Sarah Tishkoff named to receive the 2024 Vanderbilt Prize in Biomedical Science

Sarah Tishkoff, PhD, and her collaborators have created one of the world’s largest databases of African diversity derived from genetic samples from more than 9,000 people representing more than 200 diverse ethnic groups.

By Bill Snyder
July 1, 2024

Jennifer McGugin and Amy Hampton take on Managing Counsel roles in VUMC’s Office of Legal Affairs

Jennifer McGugin, JD, and Amy D. Hampton, JD, join Dawn R. Crumel, JD, and Kathleen C. Hanbury, JD, in Managing Counsel roles.
By Nancy Humphrey
July 1, 2024

Vanderbilt mourns the loss of neonatal medicine pioneer Mildred Stahlman

Mildred T. Stahlman, MD, who pioneered the treatment of lung disease in premature infants and who was a tireless advocate of children of all ages, died June 29. She was 101.
By Bill Snyder
June 28, 2024

Antibody trial launched to address enterovirus threat

Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis.
By Bill Snyder
June 27, 2024

Finding connections in the midst of loneliness

There are lonely people at Vanderbilt. There are also ways to connect and find help.
By Wayne Wood
June 26, 2024

Anderson Bottomy elected to national nursing association leadership role 

The American Association of Men in Nursing aims "to shape the practice, education, research and leadership for men in nursing and advance men’s health."
By Matt Batcheldor
June 26, 2024

State of the Department of Medicine address highlights tremendous growth 

Department of Medicine clinicians see patients in 19 counties across Middle Tennessee as well as the surrounding region. There were 86,096 outpatient visits for fiscal year 2024, an increase of more than 25,000 visits over fiscal year 2023.
By Nancy Humphrey
June 25, 2024

International trial introduces another curative option for sickle cell disease 

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.
By Jessica Pasley